FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/044160 [Registered on: 20/07/2022] Trial Registered Prospectively
Last Modified On: 19/07/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Randomized Clinical Trial To assess the effecacy of Aragwadhadi taila in comparison with betadine liquid in management of Dushta vrana  
Scientific Title of Study   RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF ARAGWADHADI TAILA IN COMPARISON WITH BETADINE LIQUID IN THE MANAGEMENT OF DUSHTA VRANA. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR AMRUTA ARVIND NARKAR 
Designation  M S SCHOLAR SHALYA TANTRA 
Affiliation  DR D Y PATIL DEEMED TO BE UNIVERSITY 
Address  OPD NO 3 DEPARTMENT OF SHALYATANTRA DR D Y PATIL AYURVED COLLEGE AND RESEARCH CENTRE PIMPRI PUNE SANTA TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHAWAD.
OPD NO 3 DEPARTMENT OF SHALYATANTRA DR D Y PATIL AYURVED COLLEGE AND RESEARCH CENTRE PIMPRI PUNE SANTA TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHAWAD.
Pune
MAHARASHTRA
411018
India 
Phone  9967111390  
Fax    
Email  narkaramruta13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SANJAY BABAR 
Designation  PROFESSOR 
Affiliation  DR D Y PATIL DEEMED TO BE UNIVERSITY 
Address  OPD NO 3 DEPARTMENT OF SHALYATANTRA DR D Y PATIL AYURVED COLLEGE AND RESEARCH CENTRE PIMPRI PUNE SANTA TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHAWAD.
OPD NO 3 DEPARTMENT OF SHALYATANTRA DR D Y PATIL AYURVED COLLEGE AND RESEARCH CENTRE PIMPRI PUNE SANTA TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHAWAD.
Pune
MAHARASHTRA
411018
India 
Phone  9011035602  
Fax    
Email  sanjaybabar14@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR AMRUTA ARVIND NARKAR 
Designation  M S SCHOLAR SHALYA TANTRA 
Affiliation  DR D Y PATIL DEEMED TO BE UNIVERSITY 
Address  OPD NO 3 DEPARTMENT OF SHALYATANTRA DR D Y PATIL AYURVED COLLEGE AND RESEARCH CENTRE PIMPRI PUNE SANTA TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHAWAD.
OPD NO 3 DEPARTMENT OF SHALYATANTRA DR D Y PATIL AYURVED COLLEGE AND RESEARCH CENTRE PIMPRI PUNE SANTA TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHAWAD.
Pune
MAHARASHTRA
411018
India 
Phone  9967111390  
Fax    
Email  narkaramruta13@gmail.com  
 
Source of Monetary or Material Support  
DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE DEEMED TO BE UNIVERSITY 
 
Primary Sponsor  
Name  DR AMRUTA ARVIND NARKAR  
Address  DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE DEEMED TO BE UNIVERSITY 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NILL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR AMRUTA ARVIND NARKAR  DR AMRUTA ARVIND NARKAR  OPD NO.3 Graud Floor, DEPARTMENT OF SHALYATANTRA DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI Pune 18, SANT TUKARAM NAGAR PIMPRI COLONY PIMPRI CHINCHWAD
Pune
MAHARASHTRA 
9967111390

narkaramruta13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethical Commitee Meeting  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L089||Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DUSHTAVRANAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  ARAGWADHADI TAILA  30 patients will be selected and treated with aragwadhadi taila as per required. duration of study 15 days Dose:As Per requirement Route : Local Application Duration :15 Days  
Comparator Agent  BETADINE LIQUID   30 patients will be selected and treated with betadine liquid as per required. duration of study 15 days Dose: As per requirement. Route: Local Application Duration:15 Days  
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patients having sign and symptoms of Dushta Vrana i.e.infected wound.
2.Dushta Vrana size up to 5×5cms (LxB)
3.Patients of either sex will be selected.
4.The patients of age group 19 - 70 years
 
 
ExclusionCriteria 
Details  1.Anaemic patient Hb < 10 gm
2.Malnourished patient (as per age, height and weight proportion)
3.Bleeding disorders (increased B.T and C.T)
4.Patient with septicemia
5.The patients suffering from systemic disease such as AIDS, Tuberculosis, Uncontrolled Diabetes mellitus, Hepatitis-B, Malignancy, Vericose ulcer, Deep vein thrombosis, Neurogenic ulcer, Leukemia, etc.
6.Any congenital diseases or abnormalities.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1)Dushta vrana (infected wound) has been explained as a stage of vrana in many classical texts. Also, Dushta vrana (infected wound) has been mentioned as a type of vrana (wound).
2)To evaluate the eshtablish safer, cost-effective aragwadhadi taila in the management of dushta vrana (infected wound) 
15 Days of study (0,5,10,15 days) 
 
Secondary Outcome  
Outcome  TimePoints 
Aragwadhadi Taila is effective management of dushta vrana  15 days of study (0,5,10,15) 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   25/07/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  25/07/2022 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   aim of the study will be to give ayurvedic treatment to diseased patient to improve his / her condition and we can give his / her cheap, safe side effect free management. The trial will be conducted on 60 patients for follow up of 0,5,10,15 days and doses of drug as per required once a day for 15 days with 4 follow up (0,5,10,15 days ) 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   aim of the study will be to give ayurvedic treatment to diseased patient to improve his / her condition and we can give his / her cheap, safe side effect free management. The trial will be conducted on 60 patients for follow up of 0,5,10,15 days and doses of drug as per required once a day for 15 days with 4 follow up (0,5,10,15 days ) 
Close